From October 1, 2021 to December 31, 2021, the company has repurchased 20,452 shares, representing 0.17% for KRW 2,279.19 million. With this, the company has completed the repurchase of 110,665 shares, representing 0.93% for KRW 14,904.82 million under the buyback announced on October 15, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
101,700 KRW | +0.30% |
|
-4.69% | -22.31% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.31% | 936M | |
+20.37% | 43.54B | |
+19.44% | 21.78B | |
+17.85% | 15.38B | |
+25.55% | 15.12B | |
+60.99% | 13.36B | |
-0.05% | 6.79B | |
-15.02% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.32B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.